We recommend the use of extended phenotyping, including ABO, RH, Kell, Duffy, Kidd, and MNS blood group systems, in transfusion practice for patients with sickle cell disease and thalassemia in the Al-Ahsa Region. This evidence concerns the gene ABO and sickle cell disease.